Per B. Fischer

1.3k total citations · 1 hit paper
11 papers, 999 citations indexed

About

Per B. Fischer is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Per B. Fischer has authored 11 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 3 papers in Molecular Biology. Recurrent topics in Per B. Fischer's work include Streptococcal Infections and Treatments (7 papers), Neonatal and Maternal Infections (7 papers) and Pneumonia and Respiratory Infections (5 papers). Per B. Fischer is often cited by papers focused on Streptococcal Infections and Treatments (7 papers), Neonatal and Maternal Infections (7 papers) and Pneumonia and Respiratory Infections (5 papers). Per B. Fischer collaborates with scholars based in Denmark, Sweden and United Kingdom. Per B. Fischer's co-authors include Robert B. Sim, Pauline M. Rudd, Raymond A. Dwek, Rajneesh Malhotra, Mark R. Wormald, Søren K. Moestrup, P Verroust, Henrik Birn, C. M. Petersen and Erik Christensen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and FEBS Letters.

In The Last Decade

Per B. Fischer

11 papers receiving 971 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein

1995 620 citations Rajneesh Malhotra, Mark R. Wormald et al. Nature Medicine profile →

Peers

Countries citing papers authored by Per B. Fischer

Since Specialization

Citations

This map shows the geographic impact of Per B. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per B. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per B. Fischer more than expected).

Fields of papers citing papers by Per B. Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per B. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per B. Fischer. The network helps show where Per B. Fischer may publish in the future.

Co-authorship network of co-authors of Per B. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Per B. Fischer. A scholar is included among the top collaborators of Per B. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per B. Fischer. Per B. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Preclinical development of a novel Group B Streptococcus (GBS) vaccine candidate for maternal immunization based upon the alpha‐like protein family of GBS surface proteins (Alp) 2023 ·Birth Defects Research ·(unknown), (unknown), (unknown), Michael J. Darsley, Per B. Fischer	9
2	Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial 2023 ·iScience ·(unknown), A Pawłowski, Janne Lehtonen, Duojia Cao, Sara Larsson, Michael J. Darsley, (unknown), Per B. Fischer, Bengt Johansson‐Lindbom	14
3	A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains 2022 ·Cell Reports Medicine ·A Pawłowski, Jonas Lannergård, (unknown), Duojia Cao, Sara Larsson, Jenny Persson, (unknown), Michael J. Darsley, Ane Lilleøre Rom, Morten Hedegaard, Per B. Fischer, Bengt Johansson‐Lindbom	23
4	A Recombinant Alpha-Like Protein Subunit Vaccine (GBS-NN) Provides Protection in Murine Models of Group B Streptococcus Infection 2022 ·The Journal of Infectious Diseases ·(unknown), (unknown), Phoenicia Quach, (unknown), (unknown), Bengt Johansson‐Lindbom, Per B. Fischer, Lakshmi Rajagopal	15
5	Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women 2021 ·Vaccine ·Per B. Fischer, A Pawłowski, Duojia Cao, David Bell, (unknown), Michael J. Darsley, Bengt Johansson‐Lindbom	37
6	Serocorrelates of protection against infant group B streptococcus disease 2019 ·The Lancet Infectious Diseases ·Kirsty Le Doaré, Beate Kampmann, Johan Vekemans, Paul T. Heath, David Goldblatt, Moon H. Nahm, Carol J. Baker, Morven S. Edwards, Gaurav Kwatra, Nick Andrews, Shabir A. Madhi, (unknown), Annaliesa S. Anderson, (unknown), Per B. Fischer, Andrew Gorringe	44
7	Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN 2018 ·Molecular Pharmaceutics ·Fabrice Rose, Silke Roovers, (unknown), (unknown), Jacob J. K. Kirkensgaard, Kim R. Hejnæs, Per B. Fischer, Camilla Foged	2
8	Affinity and kinetic analysis of the bovine plasma C‐type lectin collectin‐43 (CL‐43) interacting with mannan 1996 ·FEBS Letters ·Uffe Holmskov, Per B. Fischer, (unknown), Peter Højrup	23
9	Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. 1996 ·Proceedings of the National Academy of Sciences ·Søren K. Moestrup, Henrik Birn, Per B. Fischer, C. M. Petersen, P Verroust, Robert B. Sim, Erik Christensen, Ebba Nexø	175
10	Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein breakdown → 1995 ·Nature Medicine ·Rajneesh Malhotra, Mark R. Wormald, Pauline M. Rudd, Per B. Fischer, Raymond A. Dwek, Robert B. Sim	620
11	Mannan‐Binding Protein and Bovine Conglutinin Mediate Enhancement of Herpes Simplex Virus Type 2 Infection in Mice 1994 ·Scandinavian Journal of Immunology ·Per B. Fischer, Svend Ellermann‐Eriksen, Steffen Thiel, (unknown), Søren C. Mogensen	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact